Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Not Confirmed
Not Confirmed
04-06 December, 2025
Not Confirmed
Not Confirmed
05-09 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Cosmoprof IndiaCosmoprof India
Industry Trade Show
Not Confirmed
04-06 December, 2025
Industry Trade Show
Not Confirmed
05-09 December, 2025
Digital content

20 Nov 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-11-20/alvotech-and-advanz-pharma-receive-marketing-approval-across-the-european-economic-area-for-gobivaz-a-first-in-market-biosimilar-to-simponi-golimu

06 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/06/3182645/0/en/Alvotech-and-Advanz-Pharma-Receive-Marketing-Authorisations-for-Gobivaz-a-Biosimilar-to-Simponi-golimumab-from-the-MHRA.html

06 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/06/3161486/0/en/European-Marketing-Application-for-AVT23-a-Proposed-Biosimilar-to-Xolair-omalizumab-Accepted-by-the-European-Medicines-Agency.html

22 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/22/3153691/0/en/European-Medicines-Agency-Recommends-Marketing-Approval-of-Gobivaz-Alvotech-s-Proposed-Biosimilar-to-Simponi-golimumab-with-Advanz-Pharma-as-Commercialization-Partner.html

21 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/21/3136921/0/en/Advanz-Pharma-and-Alvotech-receive-European-approval-for-Mynzepli-Biosimilar-to-Eylea.html

21 Aug 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/advanz-pharma-alvotech-gain-european-approval-for-mynzepli/
ABOUT THIS PAGE